BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9868303)

  • 1. [Multi-parametric analysis for leukemic immunophenotyping].
    Ujiie M; Sonoda A; Todoroki T; Amano H; Uchida T; Kawai Y; Watanabe K
    Rinsho Byori; 1998 Nov; 46(11):1163-7. PubMed ID: 9868303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochemical and immunological phenotying of acute nonlymphoblastic leukemia in Thai patients.
    Pokatikorn W; Apibal S; Atichartakarn V; Sriurairatana S; Chiewsilp D; Thitikawin P; Timvipark C
    J Med Assoc Thai; 1996 Nov; 79(11):708-14. PubMed ID: 8997009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunophenotypic analysis in acute leukemia].
    Akashi K; Harada M
    Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
    Ratei R; Sperling C; Ludwig WD
    Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
    Piedras J; López-Karpovitch X; Cárdenas R
    Cytometry; 1998 Aug; 32(4):286-90. PubMed ID: 9701397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
    Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
    Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
    Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemias of indeterminant lineage.
    Lee EJ; Schiffer CA
    Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A; Robak T
    Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of immunophenotyping on management of acute leukemias.
    Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
    Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.